Crossmark

Early warnings and repayment plans: novel trial management methods for monitoring and managing data return rates in a multi-centre phase III randomised controlled trial with paper Case Report Forms

Crossref DOI link: https://doi.org/10.1186/s13063-019-3343-2

Published: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cragg, William J. http://orcid.org/0000-0002-1274-8521
Cafferty, Fay http://orcid.org/0000-0002-0973-660X
Diaz-Montana, Carlos http://orcid.org/0000-0001-9082-4596
James, Elizabeth C. http://orcid.org/0000-0002-0490-7211
Joffe, Johnathan http://orcid.org/0000-0001-7249-8379
Mascarenhas, Monica http://orcid.org/0000-0002-4623-3147
Yorke-Edwards, Victoria http://orcid.org/0000-0002-6465-7330
Funding

Funding for this research was provided by:

Cancer Research UK (C17084/A8690)

Medical Research Council (MC_UU_12023/24, MC_UU_12023/28)
License Information

Text and Data Mining valid from 2019-04-27
More Information

Article History

Received: 28 August 2018

Accepted: 3 April 2019

First Online: 27 April 2019

Ethics approval and consent to participate

: No ethical approval was required for this work in particular, but the TRISST trial was approved by the Leeds East Research Ethics Committee (now Yorkshire and the Humber—Leeds East) prior to commencing (reference number 07/H1306/127).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below